Martin L. Sos

Kerpener Str. 62
Koeln, NW 50937, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 51 publications

AURORA A interacts with DICER and SETD2 to promote S-phase progression.

AURORA A interacts with DICER and SETD2 to promote S-phase progression.

Journal: EMBO reports

Published: October 29, 2025

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr-mutated lung cancer.

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr-mutated lung cancer.

Journal: Molecular oncology

Published: October 07, 2025

Publisher Correction: Functional synapses between neurons and small cell lung cancer.

Publisher Correction: Functional synapses between neurons and small cell lung cancer.

Journal: Nature

Published: September 19, 2025

Tolerance and Resistance to Targeted Therapy in NSCLC: Emerging Concepts and Strategies.

Tolerance and Resistance to Targeted Therapy in NSCLC: Emerging Concepts and Strategies.

Journal: JTO clinical and research reports

Published: September 09, 2025

Editor's Note: PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR.

Editor's Note: PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR.

Journal: Cancer research

Published: December 31, 2024

Differential KEAP1/NRF2 mediated signaling widens the therapeutic window of redox-targeting drugs in SCLC therapy.

Differential KEAP1/NRF2 mediated signaling widens the therapeutic window of redox-targeting drugs in SCLC therapy.

Journal: Nature communications

Published: October 23, 2024

A disease model resource reveals core principles of tissue-specific cancer evolution.

A disease model resource reveals core principles of tissue-specific cancer evolution.

Journal: Nature

Published: October 11, 2024

CDK9 inhibition as an effective therapy for small cell lung cancer.

CDK9 inhibition as an effective therapy for small cell lung cancer.

Journal: Cell death & disease

Published: November 13, 2023

Functional synapses between neurons and small cell lung cancer.

Functional synapses between neurons and small cell lung cancer.

Journal: Nature

Published: December 20, 2022

Characterizing Evolutionary Dynamics Reveals Strategies to Exhaust the Spectrum of Subclonal Resistance in EGFR-Mutant Lung Cancer.

Characterizing Evolutionary Dynamics Reveals Strategies to Exhaust the Spectrum of Subclonal Resistance in EGFR-Mutant Lung Cancer.

Journal: Cancer research

Published: August 17, 2022

Resistance to MET inhibition in MET-dependent NSCLC and therapeutic activity after switching from type I to type II MET inhibitors.

Resistance to MET inhibition in MET-dependent NSCLC and therapeutic activity after switching from type I to type II MET inhibitors.

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 03, 2022

Insight into Targeting Exon20 Insertion Mutations of the Epidermal Growth Factor Receptor with Wild Type-Sparing Inhibitors.

Insight into Targeting Exon20 Insertion Mutations of the Epidermal Growth Factor Receptor with Wild Type-Sparing Inhibitors.

Journal: Journal of medicinal chemistry

Published: April 29, 2022

Showing 1-12 of 51

Last Updated: 09/26/2026